K67, a compound that interferes with the interaction between phospho-p62 and Keap1, resulting in the restoration of the Keap1-Nrf2 binding, has been shown to render cancer cells sensitive to anti-cancer drugs [49]. Here, KEAP1 is linked to cancer.